The Effects of Converting Enzyme Inhibition

  • Thomas G. Coleman
Part of the Blood Pressure Control book series (BPCO, volume 1)


Several compounds have been discovered or created that inhibit angiotensin converting enzyme and thereby dramatically slow the conversion of angiotensin I to angiotensin II. One of these, captopril, has been widely used as an experimental tool and is currently being evaluated for routine clinical use because it can be administered orally.


Arterial Pressure Angiotensin Converting Enzyme Converting Enzyme Plasma Renin Activity Renal Blood Flow 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Eden Press Incorporated 1980

Authors and Affiliations

  • Thomas G. Coleman
    • 1
  1. 1.School of Medicine Department of Physiology and BiophysicsThe University of Mississippi Medical CenterJacksonUSA

Personalised recommendations